Clinical Trials

New Search
Title   A Phase 2, Randomized, Double-Blind, Dose-Ranging Study to Determine the Pharmacokinetics, Safety and Tolerability of Vedolizumab IV in Pediatric Subjects With Ulcerative Colitis or Crohn's Disease
Disease/Condition   Gastroenterology & Liver Diseases,Pediatrics,Inflammatory Bowel Disease,Colitis and Crohn's Disease
Eligibility Criteria   Click here for eligibility requirements
Principal Investigator   John Thompson, MD
Contact Name   Preeti Malik
Contact Email   pmalik@montefiore.org
IRB/Protocol Number   18-10-218-01
Status   Active/Enrolling
Adult Clinical Trial   No
Pediatric Clinical Trial   Yes
Sub-Specialty   Pediatric Gastroenterology - Crohn's Disease